China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics


China Pharma Holdings, Inc. (CPHI): $0.21

0.00 (-1.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CPHI to Watchlist
Sign Up

Industry: China


Ranked

of

in industry

CPHI Stock Summary

  • CPHI has a higher market value than only 2.88% of US stocks; more precisely, its current market capitalization is $19,409,218.
  • The price/operating cash flow metric for China Pharma Holdings Inc is higher than 92.73% of stocks in our set with a positive cash flow.
  • Revenue growth over the past 12 months for China Pharma Holdings Inc comes in at -11.84%, a number that bests only 10.02% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to China Pharma Holdings Inc, a group of peers worth examining would be CETX, MGIC, IOSP, ORGO, and OFLX.
  • Visit CPHI's SEC page to see the company's official filings. To visit the company's web site, go to www.chinapharmaholdings.com.

CPHI Valuation Summary

  • CPHI's EV/EBIT ratio is -10.3; this is 135.15% lower than that of the median Healthcare stock.
  • CPHI's price/earnings ratio has moved down 10.5 over the prior 154 months.
  • Over the past 154 months, CPHI's price/earnings ratio has gone down 10.5.

Below are key valuation metrics over time for CPHI.

Stock Date P/S P/B P/E EV/EBIT
CPHI 2021-08-31 3.0 4.6 -7.8 -10.3
CPHI 2021-08-30 2.9 4.6 -7.8 -10.3
CPHI 2021-08-27 3.0 4.7 -8.1 -10.6
CPHI 2021-08-26 3.1 4.9 -8.3 -10.9
CPHI 2021-08-25 3.1 4.9 -8.3 -10.9
CPHI 2021-08-24 3.1 4.8 -8.3 -10.8

CPHI Growth Metrics

    Its 3 year revenue growth rate is now at -36.36%.
  • Its 3 year price growth rate is now at 41%.
  • Its year over year net income to common stockholders growth rate is now at 85.8%.
Over the past 33 months, CPHI's revenue has gone down $2,647,026.

The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 9.683661 0.283142 -3.627794
2021-06-30 10.1057 0.5096 -3.811021
2021-03-31 11.46087 -0.075021 -2.973207
2020-12-31 10.86645 -0.04226 -2.866777
2020-09-30 10.98376 -1.172494 -20.403
2020-06-30 10.95993 -0.476228 -20.09405

CPHI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
  • CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
  • DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.

The table below shows CPHI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.493 0.094 -0.236
2021-03-31 0.538 0.177 -0.174
2020-12-31 0.495 0.180 -0.168
2020-09-30 0.494 0.153 -1.332
2020-06-30 0.407 0.183 -0.990
2020-03-31 0.306 0.105 -0.802

CPHI Stock Price Chart Interactive Chart >

Price chart for CPHI

CPHI Price/Volume Stats

Current price $0.21 52-week high $0.97
Prev. close $0.22 52-week low $0.20
Day low $0.21 Volume 108,000
Day high $0.23 Avg. volume 201,702
50-day MA $0.25 Dividend yield N/A
200-day MA $0.42 Market Cap 10.37M


CPHI Latest News Stream


Event/Time News Detail
Loading, please wait...

CPHI Latest Social Stream


Loading social stream, please wait...

View Full CPHI Social Stream

Latest CPHI News From Around the Web

Below are the latest news stories about China Pharma Holdings Inc that investors may wish to consider to help them evaluate CPHI as an investment opportunity.

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended September 30, 2021.

Yahoo | November 12, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning, investor!

William White on InvestorPlace | October 28, 2021

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the quarter ended June 30, 2021.

Yahoo | August 13, 2021

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its Candesartan hypertension product passed key bioequivalence tests. The Company plans to use the results of the key benchmark tests of consistency evaluation to apply for the National Medical Products Administration's (NMPA) approval. The NMPA is the Chinese agency for regulating drugs and medical devices (formerly the China Food and Drug Administr

Yahoo | August 5, 2021

China Pharma to Launch Highly Purified NMN+PQQ Product

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale test. β-Nicotinamide mononucleotide (NMN) is a derivative of the B-vitamin niacin, which is believed to significantly improve health and wellness.

Yahoo | June 9, 2021

Read More 'CPHI' Stories Here

CPHI Price Returns

1-mo -17.65%
3-mo -46.02%
6-mo -56.49%
1-year -70.60%
3-year -28.81%
5-year -8.70%
YTD -56.49%
2021 8.25%
2020 88.26%
2019 -7.86%
2018 42.78%
2017 -30.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5365 seconds.